NCT05538832CompletedEarly phase 1
Remote State Representation in Early Psychosis
Source: ClinicalTrials.gov · Last updated 3 Oct 2025
Brief summary (registry, in English)
The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.
- Status (registry)
- Completed
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 152 (actual)
- First submitted
- 5 Aug 2022
- Start date
- 27 Jul 2022
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- University of Minnesota
- Diseases
- Schizophrenia
- NCT number
- NCT05538832
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 152
- From 27 Jul 2022 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous clinically significant head injury or prolonged unconsciousness
Other illness
- History of severe substance use in the past 3 months (determined by interview)
- Diagnosed with a neurological disorder that would impede participation in the study or would put the participant at additional risk by participating, in the opinion of the PI/CO-Is
- Meets DSM-5 criteria for a psychotic, bipolar, or autism spectrum disorder
- Has a family history (1st degree relative) of psychosis, bipolar, or autism spectrum disorders
Other
- All participants:
- Unable to demonstrate capacity to consent to research, in the judgment of the study team
- Significant cognitive training experience in the past 6 months
- Meets criteria for clinical risk of suicidal behavior.
- Non-Psychosis participants:
Who the study is looking for
- All Participants:
- Between the ages of 18-30 at the time of screening
- Fluent in spoken and written English, in that the participant learned to speak English before the age of 12 or is able to demonstrate fluency in conversation with study staff
- Has an outpatient status and no hospitalization for psychiatric reasons for at least 1 month prior to participant
- Has access to a computer with internet connection
- Has a United States address as permanent residence
- Estimated IQ at or above 70, as estimated by the cognitive assessments
- Early Psychosis Participants:
- Diagnosis of one of the following conditions (confirmed via interview): schizophrenia; schizoaffective disorder; schizophreniform disorder; Psychosis not otherwise specified (NOS); major depressive disorder with psychotic features; bipolar disorder with psychotic features
- Willing to share contact with a clinical provider
Age in the registry: 18 years to 30 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.